<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 11 Feb 2021 23:27:23 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>医药魔方Pro祝您新春快乐，牛年大吉！</title><link>https://mp.weixin.qq.com/s/hvnJi3g74pESge4OwVqG-w</link><description></description><content:encoded><![CDATA[医药魔方Pro祝您新春快乐，牛年大吉！]]></content:encoded><pubDate>Thu, 11 Feb 2021 20:58:44 +0800</pubDate></item><item><title>Science报道抗衰老突破疗法！GLS1抑制剂可高效清除衰老细胞，缓解NASH等疾病症状</title><link>https://mp.weixin.qq.com/s/z6SRfDlL8OTkFLdiw_pZjA</link><description></description><content:encoded><![CDATA[Science报道抗衰老突破疗法！GLS1抑制剂可高效清除衰老细胞，缓解NASH等疾病症状]]></content:encoded><pubDate>Wed, 10 Feb 2021 21:03:19 +0800</pubDate></item><item><title>数万名患者数据揭示：中国男性NSCLC患者KRAS G12C突变频率高于女性</title><link>https://mp.weixin.qq.com/s/8Yh3RWT_1EZQcbOV3vCJuA</link><description></description><content:encoded><![CDATA[数万名患者数据揭示：中国男性NSCLC患者KRAS G12C突变频率高于女性]]></content:encoded><pubDate>Tue, 09 Feb 2021 21:00:47 +0800</pubDate></item><item><title>制药巨头群雄逐鹿：从AI到量子计算，药物研发快车道蓄势待发</title><link>https://mp.weixin.qq.com/s/p7N1hC-mTGudf6zt0LB1hA</link><description></description><content:encoded><![CDATA[制药巨头群雄逐鹿：从AI到量子计算，药物研发快车道蓄势待发]]></content:encoded><pubDate>Mon, 08 Feb 2021 21:01:38 +0800</pubDate></item><item><title>超18亿美元！CAR-NK细胞疗法领域又一大交易，继赛诺菲后默沙东也出手了</title><link>https://mp.weixin.qq.com/s/EeELbVe2CV5A2uuwobZKuQ</link><description></description><content:encoded><![CDATA[超18亿美元！CAR-NK细胞疗法领域又一大交易，继赛诺菲后默沙东也出手了]]></content:encoded><pubDate>Sun, 07 Feb 2021 20:58:53 +0800</pubDate></item><item><title>可全身给药，新型胰腺癌溶瘤病毒疗法来了！</title><link>https://mp.weixin.qq.com/s/Tcj9zhK6MrHY4a8ufpea2Q</link><description></description><content:encoded><![CDATA[可全身给药，新型胰腺癌溶瘤病毒疗法来了！]]></content:encoded><pubDate>Sat, 06 Feb 2021 20:59:04 +0800</pubDate></item><item><title>胞内免疫检查点，能否助力解决PD-1抗体耐药性？</title><link>https://mp.weixin.qq.com/s/FUKqsJGNaFA9X8k7BvOu3Q</link><description></description><content:encoded><![CDATA[胞内免疫检查点，能否助力解决PD-1抗体耐药性？]]></content:encoded><pubDate>Fri, 05 Feb 2021 21:00:26 +0800</pubDate></item><item><title>过去二十年，癌症研究30项里程碑 | Nature年度巨献</title><link>https://mp.weixin.qq.com/s/iTmFoCc5ZAgPlpMr8C0lJA</link><description></description><content:encoded><![CDATA[过去二十年，癌症研究30项里程碑 | Nature年度巨献]]></content:encoded><pubDate>Thu, 04 Feb 2021 21:00:30 +0800</pubDate></item><item><title>最新版全球癌症负担报告：乳腺癌超越肺癌成第一大癌，中国2020年新增457万癌症病例</title><link>https://mp.weixin.qq.com/s/TzEC4lA0-WdQ69rQUL_qZw</link><description></description><content:encoded><![CDATA[最新版全球癌症负担报告：乳腺癌超越肺癌成第一大癌，中国2020年新增457万癌症病例]]></content:encoded><pubDate>Wed, 03 Feb 2021 21:01:06 +0800</pubDate></item><item><title>陈枢青点评 | 新抗原疫苗：开启癌症免疫治疗2.0时代</title><link>https://mp.weixin.qq.com/s/dvrF6zgj_4U4tIxIrmhmaw</link><description></description><content:encoded><![CDATA[陈枢青点评 | 新抗原疫苗：开启癌症免疫治疗2.0时代]]></content:encoded><pubDate>Tue, 02 Feb 2021 20:58:32 +0800</pubDate></item></channel></rss>